Alan D. Sobel
CIK: 0001639386
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cytosorbents Corp
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 15, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct1.9K shares at avg. $6.12$12K - Sep 15, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct500 shares at avg. $6.05$3K - Sep 15, 2026CTSO
Cytosorbents Corp
Purchase(P)Direct100 shares at avg. $6.01$601 - Aug 8, 2025CTSO
Cytosorbents Corp
Award(A)DirectStock Option (Right to Buy)
22K shares- - Feb 24, 2025CTSO
Cytosorbents Corp
Out-of-Term(O)Direct22K shares at avg. $1.13$25K - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries A Right Warrants
22K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
Other(J)DirectSeries B Right Warrants
22K shares- - Jan 17, 2025CTSO
Cytosorbents Corp
In-the-Money(X)Direct22K shares at avg. $1.00$22K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 1,900 | $6.12 | $11,628 | Direct |
| Sep 15, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 500 | $6.05 | $3,025 | Direct |
| Sep 15, 2026 | CTSO Cytosorbents Corp | Purchase(P) | 100 | $6.01 | $601 | Direct |
| Aug 8, 2025 | CTSO Cytosorbents Corp | Award(A) Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Feb 24, 2025 | CTSO Cytosorbents Corp | Out-of-Term(O) | 21,950 | $1.13 | $24,803 | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series A Right Warrants | 21,950 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | Other(J) Series B Right Warrants | 21,950 | - | - | Direct |
| Jan 17, 2025 | CTSO Cytosorbents Corp | In-the-Money(X) | 21,950 | $1.00 | $21,950 | Direct |
1-8 of 8 transactions
About Sobel Alan D.
Sobel Alan D. (SEC CIK 0001639386) files insider reports with the SEC as Director of Cytosorbents Corp (CTSO).
Signal8 holds 4 ownership filings by Sobel Alan D., all Form 4s, filed between Jan 22, 2025 and Sep 16, 2026. Those filings report 8 transactions, from Jan 17, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sobel Alan D.'s filings is in PRINCETON, NJ.
Recent filings by Sobel Alan D.
- Sep 15, 2026: Open-market purchases of CTSO shares (3 lines, Form 4, code P).
- Aug 8, 2025: Grant or award of CTSO derivative securities (Form 4, code A).
- Feb 24, 2025: Out-of-the-money exercise transaction of CTSO shares (Form 4, code O).
- Jan 17, 2025: Other transactions of CTSO derivative securities (2 lines, Form 4, code J).
- Jan 17, 2025: Option exercise of CTSO shares (Form 4, code X).
Other insiders filing for Cytosorbents Corp (CTSO)
- Chan Phillip P., Chief Executive Officer
- Capponi Vincent, President and COO
- MARIANI PETER J, Chief Financial Officer
- Jones Edward Raymond, Director
- BATOR MICHAEL G., Director
- Kim Jiny, Director